Get started
Author

Angela Williams

Observed name: Williams, Angela
ORCID: 0009-0003-8537-5468
Observed ORCID: 0009-0003-8537-5468
OpenAlex ID: A5130797018
The lived experience of adolescents with X-linked hypophosphataemia treated with burosumab at end of skeletal growth: a mixed-methods analysis
2026 · Vrinda Saraff, Pedro Arango Sancho, et al. · PLoS ONE · 1
PDF
Adolescents’ experience of living with X-linked hypophosphataemia (XLH): a mixed-methods analysis of those who continued and discontinued burosumab treatment after end of skeletal growth
2026 · Vrinda Saraff, Pedro Arango-Sancho, et al. · Orphanet Journal of Rare Diseases
Adolescents’ experience of living with X-linked hypophosphataemia (XLH): a mixed-methods analysis of those who continued and discontinued burosumab treatment after end of skeletal growth
2026 · Saraff, Vrinda, Arango-Sancho, Pedro, et al. · Figshare
Additional file 1 of Adolescents’ experience of living with X-linked hypophosphataemia (XLH): a mixed-methods analysis of those who continued and discontinued burosumab treatment after end of skeletal growth
2026 · Saraff, Vrinda, Arango-Sancho, Pedro, et al. · Figshare
Works count: 4
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type